In conclusion, mTOR and c‐Myc are important for lymphangiogenesis of pNET and are potential therapeutic targets for prevention and treatment of lymph node metastasis in pNET. This evidence concerns the gene MYC and metastatic malignant neoplasm in the lymph nodes.